Name | Symbol | Markt | Aktientyp |
---|---|---|---|
Gyre Therapeutics Inc | GYRE | NASDAQ | Common Stock |
Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
---|---|---|---|---|
15,45 | 15,17 | 15,91 | 15,29 | 15,63 |
Aktuelle News
Datum | Zeit | Quelle | Überschrift |
---|---|---|---|
13.5.2024 | 22:07 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
09.5.2024 | 22:10 | GLOBE | Gyre Therapeutics Reports First Quarter 2024 Financial.. |
09.5.2024 | 22:05 | EDGAR2 | Form 8-K - Current report |
08.5.2024 | 14:00 | EDGAR2 | Form 8-K - Current report |
26.3.2024 | 11:00 | GLOBE | Gyre Therapeutics Reports Full Year 2023 Financial Results.. |
21.3.2024 | 12:00 | GLOBE | Gyre Therapeutics Expands Board of Directors with.. |
15.12.2023 | 15:04 | PRNUS | Totus Medicines Announces Appointment of Nassim Usman,.. |
13.11.2023 | 13:00 | GLOBE | Gyre Therapeutics Presents Poster at the American.. |
02.11.2023 | 22:00 | EDGAR2 | Form 8-K - Current report |
01.11.2023 | 22:18 | EDGAR2 | Form 424B3 - Prospectus [Rule 424(b)(3)] |
01.11.2023 | 21:58 | EDGAR2 | Form SC 13D/A - General statement of acquisition of.. |